JPWO2020053239A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020053239A5 JPWO2020053239A5 JP2021537505A JP2021537505A JPWO2020053239A5 JP WO2020053239 A5 JPWO2020053239 A5 JP WO2020053239A5 JP 2021537505 A JP2021537505 A JP 2021537505A JP 2021537505 A JP2021537505 A JP 2021537505A JP WO2020053239 A5 JPWO2020053239 A5 JP WO2020053239A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- seq
- fusion protein
- antibody
- mutations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000037865 fusion proteins Human genes 0.000 claims description 93
- 108020001507 fusion proteins Proteins 0.000 claims description 93
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 60
- 150000001413 amino acids Chemical class 0.000 claims description 56
- 230000035772 mutation Effects 0.000 claims description 39
- 229910052698 phosphorus Inorganic materials 0.000 claims description 24
- 229910052717 sulfur Inorganic materials 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 20
- 102100035360 Cerebellar degeneration-related antigen 1 Human genes 0.000 claims description 13
- 102100035361 Cerebellar degeneration-related protein 2 Human genes 0.000 claims description 13
- 101000737796 Homo sapiens Cerebellar degeneration-related protein 2 Proteins 0.000 claims description 13
- 101100112922 Candida albicans CDR3 gene Proteins 0.000 claims description 12
- 101000737793 Homo sapiens Cerebellar degeneration-related antigen 1 Proteins 0.000 claims description 12
- 102000039446 nucleic acids Human genes 0.000 claims description 12
- 108020004707 nucleic acids Proteins 0.000 claims description 12
- 150000007523 nucleic acids Chemical class 0.000 claims description 12
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 11
- 229920001184 polypeptide Polymers 0.000 claims description 10
- 229910052700 potassium Inorganic materials 0.000 claims description 9
- 239000007787 solid Substances 0.000 claims description 3
- 108010003723 Single-Domain Antibodies Proteins 0.000 claims description 2
- 210000004899 c-terminal region Anatomy 0.000 description 6
- 230000027455 binding Effects 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 241000282832 Camelidae Species 0.000 description 2
- 102000021178 chitin binding proteins Human genes 0.000 description 2
- 108091011157 chitin binding proteins Proteins 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 108020001580 protein domains Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000009870 specific binding Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- OVKKNJPJQKTXIT-JLNKQSITSA-N (5Z,8Z,11Z,14Z,17Z)-icosapentaenoylethanolamine Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCO OVKKNJPJQKTXIT-JLNKQSITSA-N 0.000 description 1
- 108010011170 Ala-Trp-Arg-His-Pro-Gln-Phe-Gly-Gly Proteins 0.000 description 1
- 102000000844 Cell Surface Receptors Human genes 0.000 description 1
- 108010001857 Cell Surface Receptors Proteins 0.000 description 1
- HVLSXIKZNLPZJJ-TXZCQADKSA-N HA peptide Chemical compound C([C@@H](C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 HVLSXIKZNLPZJJ-TXZCQADKSA-N 0.000 description 1
- 101710175625 Maltose/maltodextrin-binding periplasmic protein Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000002933 Thioredoxin Human genes 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 102000034240 fibrous proteins Human genes 0.000 description 1
- 108091005899 fibrous proteins Proteins 0.000 description 1
- 102000034238 globular proteins Human genes 0.000 description 1
- 108091005896 globular proteins Proteins 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000004960 subcellular localization Effects 0.000 description 1
- 108060008226 thioredoxin Proteins 0.000 description 1
- 229940094937 thioredoxin Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18193663 | 2018-09-11 | ||
| EP18193663.4 | 2018-09-11 | ||
| EP19160485.9 | 2019-03-04 | ||
| EP19160485 | 2019-03-04 | ||
| PCT/EP2019/074153 WO2020053239A1 (en) | 2018-09-11 | 2019-09-11 | Epitope tags recognized by specific binders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022500076A JP2022500076A (ja) | 2022-01-04 |
| JPWO2020053239A5 true JPWO2020053239A5 (enExample) | 2022-09-16 |
| JP7623006B2 JP7623006B2 (ja) | 2025-01-28 |
Family
ID=68138006
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021537505A Active JP7623006B2 (ja) | 2018-09-11 | 2019-09-11 | 特異的結合剤により認識されるエピトープタグ |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12365705B2 (enExample) |
| EP (1) | EP3849996A1 (enExample) |
| JP (1) | JP7623006B2 (enExample) |
| CN (1) | CN113195516B (enExample) |
| WO (1) | WO2020053239A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250154202A1 (en) * | 2022-02-02 | 2025-05-15 | BioNTech SE | Cyclic epitope tags |
| AU2023216437A1 (en) * | 2022-02-02 | 2024-08-15 | BioNTech SE | Agents and methods for targeted delivery of nucleic acids to cells |
| AU2023215613A1 (en) * | 2022-02-02 | 2024-08-08 | BioNTech SE | Agents and methods for targeted delivery to cells |
| WO2023222580A1 (en) | 2022-05-16 | 2023-11-23 | Byondis B.V. | Novel masked antibodies |
| CN117802045A (zh) | 2022-09-30 | 2024-04-02 | 北京恩康医药有限公司 | 一种工程化细胞外囊泡的构建及其应用 |
| WO2024172152A1 (ja) * | 2023-02-17 | 2024-08-22 | 国立大学法人 東京大学 | 細胞外小胞の運命記録システム |
| WO2025021277A1 (en) * | 2023-07-21 | 2025-01-30 | BioNTech SE | Agents and methods for targeted delivery of cytokines to immune cells |
| EP4520768A1 (en) | 2023-09-06 | 2025-03-12 | BioNTech SE | Vhh-ch3 fusion proteins |
| WO2025078418A1 (en) | 2023-10-10 | 2025-04-17 | Nano Tag Biotechnologies Gmbh | Humanized single-domain antibodies binding to epitope tags |
| TW202535921A (zh) | 2023-10-11 | 2025-09-16 | 德商拜恩迪克公司 | 用於靶向遞送免疫效應子細胞之試劑及方法 |
| WO2025219955A1 (en) * | 2024-04-17 | 2025-10-23 | BioNTech SE | Soluble tcrs and methods of use thereof |
| CN120923600A (zh) * | 2024-05-09 | 2025-11-11 | 福建医科大学 | 一种超稳定红色荧光蛋白 |
| CN118909142A (zh) * | 2024-08-07 | 2024-11-08 | 北京爱思益普生物科技股份有限公司 | Irak4蛋白的制备方法及其所采用的融合蛋白 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE427968T1 (de) | 1992-08-21 | 2009-04-15 | Univ Bruxelles | Immunoglobuline ohne leichtkette |
| US20040014955A1 (en) * | 2001-12-17 | 2004-01-22 | Carlos Zamudio | Identification of essential genes of cryptococcus neoformans and methods of use |
| EP1558650A2 (en) * | 2002-11-08 | 2005-08-03 | Ablynx N.V. | Camelidae antibodies against immunoglobulin e and use thereof for the treatment of allergic disorders |
| AR067584A1 (es) * | 2007-07-20 | 2009-10-14 | Hoffmann La Roche | Un conjugado de un anticuerpo contra la cd4 y peptidos antifusogenicos |
| US7678883B2 (en) * | 2007-07-25 | 2010-03-16 | E.I. Du Pont De Nemours And Company | Solubility tags for the expression and purification of bioactive peptides |
| GB201008682D0 (en) | 2010-05-25 | 2010-07-07 | Vib Vzw | Epitope tag for affinity based applications |
| US10308679B2 (en) * | 2014-11-03 | 2019-06-04 | Merck Patent Gmbh | Soluble intein fusion proteins and methods for purifying biomolecules |
| EP3168306A1 (en) | 2015-11-16 | 2017-05-17 | ChromoTek GmbH | Epitope tag and method for detection and/or purification of tagged polypeptides |
-
2019
- 2019-09-11 WO PCT/EP2019/074153 patent/WO2020053239A1/en not_active Ceased
- 2019-09-11 CN CN201980074346.7A patent/CN113195516B/zh active Active
- 2019-09-11 JP JP2021537505A patent/JP7623006B2/ja active Active
- 2019-09-11 EP EP19782903.9A patent/EP3849996A1/en active Pending
- 2019-09-11 US US17/274,755 patent/US12365705B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2020053239A5 (enExample) | ||
| Kipriyanov et al. | Affinity enhancement of a recombinant antibody: formation of complexes with multiple valency by a single-chain Fv fragment–core streptavidin fusion | |
| JP2020186248A5 (enExample) | ||
| Dübel et al. | Bifunctional and multimeric complexes of streptavidin fused to single chain antibodies (scFv) | |
| JP7623006B2 (ja) | 特異的結合剤により認識されるエピトープタグ | |
| JP2019521643A5 (enExample) | ||
| JP2019514361A5 (enExample) | ||
| US11384141B2 (en) | Serum albumin binding antibodies for tuneable half-life extension of biologics | |
| JP2020530293A5 (enExample) | ||
| CA2561826A1 (en) | Linear single chain recombinant anti-cea/cd3/cd28 trispecific antibody | |
| WO2003046560B1 (en) | Self-assembly molecules | |
| JP2001521496A (ja) | 高い結合活性の多価および多特異的試薬 | |
| WO2021092075A1 (en) | IL-2RβγC BINDING COMPOUNDS | |
| WO2009142773A4 (en) | Multivalent fibronectin based scaffold domain proteins | |
| WO2005075507A1 (en) | Amyloid beta peptide binding polypeptide | |
| CN102686611A (zh) | 与“渐进性糖化终产物受体”结合的多肽以及包括所述多肽的组合物和方法 | |
| JP2017501728A5 (enExample) | ||
| JP2019535262A5 (enExample) | ||
| RU2016149596A (ru) | Новые полипептиды со специфическим связыванием и пути их применения | |
| CN105658228B (zh) | 结合人类补体c5的稳定多肽 | |
| JP2009525725A (ja) | 血小板抗原特異抗体の結合を中和するペプチドアプタマー並びにそれを含む診断及び治療への応用 | |
| WO2021207613A1 (en) | Frb antibodies | |
| CN115433277A (zh) | 抗cd38兔重组单克隆抗体的制备及应用 | |
| JPWO2022183074A5 (enExample) | ||
| CN107629112B (zh) | 一种高亲和性lc3蛋白靶向肽及其应用 |